Hospira Atracurium Besilate 10 mg/mL Solution for Injection 250 mg/25 mL vial

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

atracurium besilate, Quantity: 10.5 mg/mL

Disponible desde:

Hospira Australia Pty Ltd

formulario farmacéutico:

Injection, solution

Composición:

Excipient Ingredients: water for injections; benzenesulfonic acid

Vía de administración:

Intravenous

Unidades en paquete:

1 x 25 mL vial

tipo de receta:

(S1) This Schedule is intentionally blank

indicaciones terapéuticas:

Indications for the United Kingdom: Atracurium Besilate Solution for Injection is a medicine which acts as a muscle relaxant. Atracurium Besilate Solution for Injection is used during surgery to relax muscles and to assist with inserting a breathing tube and with artificial breathing. It is also used to help with artificial breathing in patients in intensive care. Indications for France: The injection solution of atracurium is used during surgery to relax the muscles as well as to facilitate the intubation of the endotracheal and assisted ventilation. It is also used to allow artificial ventilation in patients in intensive care.

Resumen del producto:

Visual Identification: A clear, colourless or faint yellow solution, essentially free from visible particulates; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estado de Autorización:

Listed (Export Only)

Fecha de autorización:

2019-02-26